US Bancorp’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13
| Closed | -$2K | – | 4157 |
|
|
2021
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 3756 |
|
|
2020
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 3631 |
|
|
2020
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 3678 |
|
|
2020
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 3704 |
|
|
2020
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 3656 |
|
|
2019
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 3537 |
|
|
2019
Q3 | $1K | Sell |
13
-10
| -43% | -$994 | ﹤0.01% | 3554 |
|
|
2019
Q2 | $2K | Hold |
23
| – | – | ﹤0.01% | 3519 |
|
|
2019
Q1 | $2K | Hold |
23
| – | – | ﹤0.01% | 3467 |
|
|
2018
Q4 | $2K | Hold |
23
| – | – | ﹤0.01% | 3469 |
|
|
2018
Q3 | $2K | Hold |
23
| – | – | ﹤0.01% | 3536 |
|
|
2018
Q2 | $2K | Sell |
23
-161
| -88% | -$13.9K | ﹤0.01% | 3528 |
|
|
2018
Q1 | $15K | Sell |
184
-19
| -9% | -$1.54K | ﹤0.01% | 3054 |
|
|
2017
Q4 | $16K | Buy |
203
+13
| +7% | +$1.08K | ﹤0.01% | 3012 |
|
|
2017
Q3 | $18K | Buy |
190
+39
| +26% | +$3.75K | ﹤0.01% | 2944 |
|
|
2017
Q2 | $17K | Buy |
151
+31
| +26% | +$3.46K | ﹤0.01% | 2942 |
|
|
2017
Q1 | $12K | Buy |
120
+33
| +38% | +$3.53K | ﹤0.01% | 3001 |
|
|
2016
Q4 | $9K | Hold |
87
| – | – | ﹤0.01% | 3068 |
|
|
2016
Q3 | $10K | Buy |
87
+20
| +30% | +$2.36K | ﹤0.01% | 3019 |
|
|
2016
Q2 | $7K | Buy |
+67
| New | +$7.78K | ﹤0.01% | 3109 |
|
US Bancorp's CBPO Position: Q2 2021 in Review
US Bancorp sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 13 shares — an estimated $2K sold.
US Bancorp first reported a position in CBPO in Q2 2016 and held it in 20 quarters. The position peaked at $18K in Q3 2017. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- US Bancorp reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- US Bancorp sold 13 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2K.
- US Bancorp first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 20 quarters.
- US Bancorp's China Biologic Products Holdings, Inc. position peaked at $18K in Q3 2017.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on US Bancorp's 13F filing for Q2 2021, filed 5 Aug 2021.